zuma-12: axi-cel as first-line therapy in high-risk large b-cell lymphoma
Published 2 years ago • 86 plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
2:17
zuma-12: axicabtagene ciloleucel as a first-line therapy in patients with high-risk lbcl
-
6:37
zuma-7: axi-cel in r/r large b-cell lymphoma
-
3:16
zuma-12: a phase 2 study of axi-cel as first-line therapy in patients with high-risk large b-cel...
-
4:11
interim results of the zuma-12 trial: car t-cell therapy for large b-cell lymphoma
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
45:26
quantum mitochondrial magic group call 1
-
7:57
two-year follow-up of zuma-3: safety and efficacy of brexu-cel in patients with r/r b-all
-
19:37
new perspectives excel 2019 | module 12: sam project 1a | penta insurance
-
3:55
zuma-12: axicabtagene ciloleucel for high-risk large b cell lymphoma
-
0:54
insights into the zuma-23 trial: axi-cel in frontline high-risk lbcl
-
2:32
zuma-1 update: durable survival in r/r dlbcl patients treated with axi-cel
-
2:59
axi-cel in older patients: data from zuma-1 and clinical use
-
1:34
zuma-1 update: safety data of axi-cel in patients with r/r dlbcl
-
2:26
zuma-5: high orr and cr for r/r inhl with axi-cel
-
4:44
zuma-7 subgroup analysis: axi-cel vs soc in elderly patients with r/r lbcl
-
2:55
updates from zuma-7: axi-cel for r/r dlbcl
-
1:25
the use of clonoseq to monitor mrd in patients with lbcl treated with axi-cel in zuma-7
-
2:52
zuma-24 preliminary analysis of axi-cel in the outpatient setting in patients with r/r lbcl
-
3:31
zuma-1 trial observations
-
4:03
axi-cel plus rituximab for r/r lbcl and updates from the zuma-14 study
-
1:08
zuma-7: overall survival benefit of axi-cel over soc in second-line lbcl